|
COX7A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.025300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.807600E-02 |
| Normal-vs-Stage2 |
4.596000E-02 |
| Normal-vs-Stage3 |
4.25550000000552E-05 |
| Normal-vs-Stage4 |
1.992200E-01 |
| Stage1-vs-Stage2 |
4.919800E-01 |
| Stage1-vs-Stage3 |
2.672000E-02 |
| Stage1-vs-Stage4 |
5.397200E-01 |
| Stage2-vs-Stage3 |
5.120000E-01 |
| Stage2-vs-Stage4 |
9.133400E-01 |
| Stage3-vs-Stage4 |
7.701400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.613400E-04 |
| Normal-vs-AfricanAmerican |
2.681400E-01 |
| Normal-vs-Asian |
2.252400E-01 |
| Caucasian-vs-AfricanAmerican |
1.641180E-01 |
| Caucasian-vs-Asian |
8.534400E-01 |
| AfricanAmerican-vs-Asian |
5.314600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.575700E-04 |
| Normal-vs-Female |
6.065600E-02 |
| Male-vs-Female |
4.309600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.558100E-02 |
| Normal-vs-Extreme_Weight |
1.331720E-02 |
| Normal-vs-Obese |
2.307800E-01 |
| Normal-vs-Extreme_Obese |
6.087600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.273800E-01 |
| Normal_Weight-vs-Obese |
6.825200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.786400E-01 |
| Extreme_Weight-vs-Obese |
7.686200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.890400E-01 |
| Obese-vs-Extreme_Obese |
8.506200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64769999999792E-05 |
| Normal-vs-Age(41-60Yrs) |
2.087700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.724500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.67590000047058E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.719900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.940500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.535800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.525000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.615180E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.974500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.021700E-02 |
| Normal-VS-Type2 PRCC |
1.59730000004465E-06 |
| Normal-VS-KIRP CIMP |
9.87154802345458E-12 |
| Normal-VS-Unclassified PRCC |
4.187600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.736300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.61390000252837E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
5.878200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.058320E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.716800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.563900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.823100E-04 |
| Normal-vs-N1 |
7.40319999747996E-08 |
| Normal-vs-N2 |
1.400060E-02 |
| N0-vs-N1 |
4.828100E-02 |
| N0-vs-N2 |
7.472600E-01 |
| N1-vs-N2 |
5.046800E-01 |
|
|
